Evaluation of the role of vitamin D in patients with psoriasis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/43929 |
Resumo: | Objectives: Investigate whether there is any association between the levels of vitamin D in the blood and the seriousness of psoriasis or its development. Methods: The study is characterized as observational, retrospective, composed of 40 patients with psoriasis who had serum vitamin D levels, who underwent clinical care at a dermatology outpatient clinic in Passo Fundo/RS, from August 2019 to June 2021. Results: Of the 40 interviewees, 60% were female and 40% male. Phototypes II and III prevailed. Regarding family health history, 50% had a history of the disease. Regarding the duration of psoriasis, the predominant group was between 1-10 years (57.5%). The most prevalent psoriasis subtype was vulgaris (62.5%). Regarding serum vitamin D results, the lowest index was 15.2 ng ̸ mL, the highest was 42.3 ng ̸ mL and the average was 25.99 ng ̸mL. In the predominant age group, between 20-40 years, the proportion of patients with vitamin D was less than 30 ng ̸mL is 83.33%. The lower the phototype, the greater the proportion of patients with suboptimal serum vitamin D. In the group of patients with disease duration > 10 years, vitamin D levels were lower. There is no extreme difference in the effectiveness of treatments when analyzing the average, minimum and maximum serum levels of vitamin D. Conclusion: There was no relationship between serum levels of 25-hydroxyvitamin D (25OHD) and the development of psoriasis or even control – worsening of the clinical picture of disease. |
id |
UNIFEI_90333af094469477bdeb0d942b8db99a |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/43929 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Evaluation of the role of vitamin D in patients with psoriasis Evaluación del papel de la vitamina D en pacientes con psoriasisAvaliação do papel da vitamina D em pacientes com psoríasePsoriasisVitamina DSistema inmunológico.PsoriasisVitamin DImmune system.PsoríaseVitamina DSistema imune.Objectives: Investigate whether there is any association between the levels of vitamin D in the blood and the seriousness of psoriasis or its development. Methods: The study is characterized as observational, retrospective, composed of 40 patients with psoriasis who had serum vitamin D levels, who underwent clinical care at a dermatology outpatient clinic in Passo Fundo/RS, from August 2019 to June 2021. Results: Of the 40 interviewees, 60% were female and 40% male. Phototypes II and III prevailed. Regarding family health history, 50% had a history of the disease. Regarding the duration of psoriasis, the predominant group was between 1-10 years (57.5%). The most prevalent psoriasis subtype was vulgaris (62.5%). Regarding serum vitamin D results, the lowest index was 15.2 ng ̸ mL, the highest was 42.3 ng ̸ mL and the average was 25.99 ng ̸mL. In the predominant age group, between 20-40 years, the proportion of patients with vitamin D was less than 30 ng ̸mL is 83.33%. The lower the phototype, the greater the proportion of patients with suboptimal serum vitamin D. In the group of patients with disease duration > 10 years, vitamin D levels were lower. There is no extreme difference in the effectiveness of treatments when analyzing the average, minimum and maximum serum levels of vitamin D. Conclusion: There was no relationship between serum levels of 25-hydroxyvitamin D (25OHD) and the development of psoriasis or even control – worsening of the clinical picture of disease.Objetivos: Investigar la asociación entre los niveles séricos de vitamina D y el pronóstico de la enfermedad. Métodos: Se trata de un estudio observacional y retrospectivo de 40 pacientes con psoriasis que tenían niveles séricos de vitamina D y fueron atendidos en um ambulatorio de dermatología en Passo Fundo/RS, entre agosto de 2019 y junio de 2021. Resultados: De los 40 entrevistados, el 60% eran mujeres y el 40% hombres. Predominaron los fototipos II y III. En cuanto a la duración de la psoriasis, el grupo predominante fue entre 1-10 años (57,5%). El subtipo de psoriasis más prevalente fue la vulgaris (62,5%). El nivel sérico de vitamina D más bajo fue de 15,2 ng ̸ mL, el más alto de 42,3 ng ̸ mL y la media de 25,99 ng ̸ mL. En el grupo de edad predominante entre 20-40 años, la proporción de pacientes con vitamina D inferior a 30 ng ̸mL es del 83,33%. Cuanto menor es el fototipo, mayor es la proporción de pacientes con vitamina D sérica inferior a la ideal. En el grupo de pacientes con duración de la enfermedad > 10 años, los niveles de vitamina D fueron inferiores. No hubo diferencias extremas en la eficacia de los tratamientos cuando se analizaron los niveles séricos medios, mínimos y máximos de vitamina D. Conclusión: No se observó ninguna relación entre los niveles séricos de 25-hidroxivitamina D (25OHD) y el desarrollo de psoriasis o incluso el pronóstico de la enfermedad.Objetivos: Investigar se há associação entre os níveis séricos de vitamina D e a gravidade da psoríase ou mesmo o seu desenvolvimento. Métodos: O estudo caracteriza-se como observacional, retrospectivo, composto por 40 pacientes com psoríase que apresentavam dosagem sérica de vitamina D e que foram atendidos em um ambulatório de dermatologia de Passo Fundo ̸RS, no período agosto de 2019 a junho de 2021. Resultados: Dos 40 entrevistados, 60% eram do sexo feminino e 40% do sexo masculino. Prevaleceram os fototipos II e III. Referente ao histórico familiar, 50% tinha histórico da doença. Sobre a duração da psoríase, o grupo predominante foi entre 1-10 anos (57,5%). O subtipo de psoríase mais prevalente foi a vulgar (62,5%). Em relação aos resultados de vitamina D sérica, o menor índice foi 15,2 ng ̸ mL, o maior foi 42,3 ng ̸ mL e a média foi 25,99 ng ̸ mL. Na faixa etária predominante, entre 20-40 anos, a proporção de pacientes com vitamina D menor que 30 ng ̸mL é de 83,33%. Quanto menor o fototipo, maior a proporção de pacientes com vitamina D sérico abaixo do ideal. No grupo de pacientes com duração da doença > 10 anos, o nível de vitamina D apresentou-se mais baixo. Não há diferença extrema quanto a eficácia dos tratamentos ao analisar a média, mínimos e máximos de níveis séricos de vitamina D. Conclusão: Não houve relação dos níveis séricos de 25-hidroxivitamina D (25OHD) e o desenvolvimento da psoríase ou mesmo do prognóstico da doença.Research, Society and Development2023-11-18info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/4392910.33448/rsd-v12i12.43929Research, Society and Development; Vol. 12 No. 12; e100121243929Research, Society and Development; Vol. 12 Núm. 12; e100121243929Research, Society and Development; v. 12 n. 12; e1001212439292525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/43929/35334Copyright (c) 2023 Isabel Caroline Zanatta Pedon; Gabriela Martins Fim ; Nathalia Kaminski Della Libera; Alexandra Brugnera Nunes de Mattos https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessPedon, Isabel Caroline Zanatta Fim , Gabriela Martins Libera, Nathalia Kaminski Della Mattos , Alexandra Brugnera Nunes de 2023-11-24T09:58:06Zoai:ojs.pkp.sfu.ca:article/43929Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2023-11-24T09:58:06Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Evaluation of the role of vitamin D in patients with psoriasis Evaluación del papel de la vitamina D en pacientes con psoriasis Avaliação do papel da vitamina D em pacientes com psoríase |
title |
Evaluation of the role of vitamin D in patients with psoriasis |
spellingShingle |
Evaluation of the role of vitamin D in patients with psoriasis Pedon, Isabel Caroline Zanatta Psoriasis Vitamina D Sistema inmunológico. Psoriasis Vitamin D Immune system. Psoríase Vitamina D Sistema imune. |
title_short |
Evaluation of the role of vitamin D in patients with psoriasis |
title_full |
Evaluation of the role of vitamin D in patients with psoriasis |
title_fullStr |
Evaluation of the role of vitamin D in patients with psoriasis |
title_full_unstemmed |
Evaluation of the role of vitamin D in patients with psoriasis |
title_sort |
Evaluation of the role of vitamin D in patients with psoriasis |
author |
Pedon, Isabel Caroline Zanatta |
author_facet |
Pedon, Isabel Caroline Zanatta Fim , Gabriela Martins Libera, Nathalia Kaminski Della Mattos , Alexandra Brugnera Nunes de |
author_role |
author |
author2 |
Fim , Gabriela Martins Libera, Nathalia Kaminski Della Mattos , Alexandra Brugnera Nunes de |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Pedon, Isabel Caroline Zanatta Fim , Gabriela Martins Libera, Nathalia Kaminski Della Mattos , Alexandra Brugnera Nunes de |
dc.subject.por.fl_str_mv |
Psoriasis Vitamina D Sistema inmunológico. Psoriasis Vitamin D Immune system. Psoríase Vitamina D Sistema imune. |
topic |
Psoriasis Vitamina D Sistema inmunológico. Psoriasis Vitamin D Immune system. Psoríase Vitamina D Sistema imune. |
description |
Objectives: Investigate whether there is any association between the levels of vitamin D in the blood and the seriousness of psoriasis or its development. Methods: The study is characterized as observational, retrospective, composed of 40 patients with psoriasis who had serum vitamin D levels, who underwent clinical care at a dermatology outpatient clinic in Passo Fundo/RS, from August 2019 to June 2021. Results: Of the 40 interviewees, 60% were female and 40% male. Phototypes II and III prevailed. Regarding family health history, 50% had a history of the disease. Regarding the duration of psoriasis, the predominant group was between 1-10 years (57.5%). The most prevalent psoriasis subtype was vulgaris (62.5%). Regarding serum vitamin D results, the lowest index was 15.2 ng ̸ mL, the highest was 42.3 ng ̸ mL and the average was 25.99 ng ̸mL. In the predominant age group, between 20-40 years, the proportion of patients with vitamin D was less than 30 ng ̸mL is 83.33%. The lower the phototype, the greater the proportion of patients with suboptimal serum vitamin D. In the group of patients with disease duration > 10 years, vitamin D levels were lower. There is no extreme difference in the effectiveness of treatments when analyzing the average, minimum and maximum serum levels of vitamin D. Conclusion: There was no relationship between serum levels of 25-hydroxyvitamin D (25OHD) and the development of psoriasis or even control – worsening of the clinical picture of disease. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-11-18 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/43929 10.33448/rsd-v12i12.43929 |
url |
https://rsdjournal.org/index.php/rsd/article/view/43929 |
identifier_str_mv |
10.33448/rsd-v12i12.43929 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/43929/35334 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 12 No. 12; e100121243929 Research, Society and Development; Vol. 12 Núm. 12; e100121243929 Research, Society and Development; v. 12 n. 12; e100121243929 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052633705349120 |